Steve R. Turner

Tipranavir (PNU-140690):  A Potent, Orally Bioavailable Nonpeptidic HIV Protease Inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide Class

Steve R. Turner, Joseph W. Strohbach, Rubén Tommasi et al. · Journal of Medicinal Chemistry · 1998 · 293 citations · Full text

Design and synthesis of potent and specific renin inhibitors containing difluorostatine, difluorostatone, and related analogs

Suvit Thaisrivongs, Donald T. Pals, Warren M. Kati et al. · Journal of Medicinal Chemistry · 1986 · 134 citations · Full text

Tetrahedral Intermediate, Bioorganic Chemistry, Pharmacotherapy +19

Structure-Based Design of Novel HIV Protease Inhibitors: Carboxamide-Containing 4-Hydroxycoumarins and 4-Hydroxy-2-pyrones as Potent Nonpeptidic Inhibitors

Suvit Thaisrivongs, Keith David Watenpaugh, W. Jeffrey Howe et al. · Journal of Medicinal Chemistry · 1995 · 121 citations · Full text

Structure-Based Design of HIV Protease Inhibitors:  Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones as Non-Peptidic Inhibitors

Suvit Thaisrivongs, Harvey I. Skulnick, Steve R. Turner et al. · Journal of Medicinal Chemistry · 1996 · 96 citations · Full text

Hiv Protease Inhibitors, Pharmacotherapy, Antiviral Drug +20

Structure-Based Design of Novel HIV Protease Inhibitors:  Sulfonamide-Containing 4-Hydroxycoumarins and 4-Hydroxy-2-pyrones as Potent Non-Peptidic Inhibitors

Suvit Thaisrivongs, Musiri N. Janakiraman, Kong-Teck Chong et al. · Journal of Medicinal Chemistry · 1996 · 88 citations

Hiv Protease Inhibitors, Peptide Science, Antiviral Drug +17